Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9368955rdf:typepubmed:Citationlld:pubmed
pubmed-article:9368955lifeskim:mentionsumls-concept:C1123019lld:lifeskim
pubmed-article:9368955lifeskim:mentionsumls-concept:C0597032lld:lifeskim
pubmed-article:9368955lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:9368955lifeskim:mentionsumls-concept:C1692321lld:lifeskim
pubmed-article:9368955pubmed:issue1lld:pubmed
pubmed-article:9368955pubmed:dateCreated1998-2-3lld:pubmed
pubmed-article:9368955pubmed:abstractTextAn immunohistochemical characterisation of neoplastic cells and peritumoural cellular infiltrate of ovine squamous cell carcinomas (OSCC) in different stages of growth was carried out using a commercially-available panel of seven antibodies, and formalin-fixed and paraffin-embedded tissue samples. Neoplastic cells reacted with the anti-keratin monoclonal antibody RCK-102 and with an anti-keratin polyclonal antibody, whereas they were unreactive with the anti-keratin monoclonal antibody NCL-5D3. The tumour cells were unreactive with the anti-vimentin polyclonal antibody. Increased numbers of CD3+ T-lymphocytes, IgG-containing plasma cells and lysozyme+ macrophages were associated with precancerous lesions (actinic keratosis) and with early OSCC. These results show that early lesions of OSCC induce an in situ cellular and humoral immune response. In advanced OSCC, the number of CD3+ T-lymphocytes and macrophages in the peri- and intratumoural cellular infiltrate remained high, whereas a significant decrease of IgG-containing plasma cells was found compared with early OSCC. This finding suggests an in situ decrease in the humoral immune response in advanced OSCC.lld:pubmed
pubmed-article:9368955pubmed:languageenglld:pubmed
pubmed-article:9368955pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9368955pubmed:citationSubsetIMlld:pubmed
pubmed-article:9368955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9368955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9368955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9368955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9368955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9368955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9368955pubmed:statusMEDLINElld:pubmed
pubmed-article:9368955pubmed:issn0034-5288lld:pubmed
pubmed-article:9368955pubmed:authorpubmed-author:PérezJJlld:pubmed
pubmed-article:9368955pubmed:authorpubmed-author:MéndezAAlld:pubmed
pubmed-article:9368955pubmed:authorpubmed-author:NOYESR MRMlld:pubmed
pubmed-article:9368955pubmed:authorpubmed-author:MartínM PMPlld:pubmed
pubmed-article:9368955pubmed:authorpubmed-author:de LaraF CFClld:pubmed
pubmed-article:9368955pubmed:issnTypePrintlld:pubmed
pubmed-article:9368955pubmed:volume63lld:pubmed
pubmed-article:9368955pubmed:ownerNLMlld:pubmed
pubmed-article:9368955pubmed:authorsCompleteYlld:pubmed
pubmed-article:9368955pubmed:pagination43-7lld:pubmed
pubmed-article:9368955pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:meshHeadingpubmed-meshheading:9368955-...lld:pubmed
pubmed-article:9368955pubmed:articleTitleOvine squamous cell carcinoma: immunocharacterisation of neoplastic cells and peritumoural cellular infiltrate.lld:pubmed
pubmed-article:9368955pubmed:affiliationDepartment of Comparative Pathology, Faculty of Veterinary Medicine, University of Córdoba, Spain.lld:pubmed
pubmed-article:9368955pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9368955pubmed:publicationTypeComparative Studylld:pubmed